Israel Active

Israel’s Montfort (reported previously) has enhanced its AI smartphone app that monitors neurological conditions. After six months of trials in Brazil, it now offers a test protocol for patients who have recovered from Covid-19 but still suffer long-lasting effects.

The ability of UV light to kill Covid-19 is well known. However, Tel Aviv University tests show UV with a wavelength of 285 nanometers kills 99.9% of the virus in 30 seconds - nearly as good as UV at 265nm. 285nm UV LED bulbs are cheaper and more readily available than 265nm.

The Israel Experience Doctors' Program has just brought 50 qualified doctors to Israel to help alleviate the coronavirus crisis. The doctors intend to make Aliya and simultaneously will prepare for Israeli medical licensing. 700 graduates of the program are already working in Israeli hospitals.

Israel’s Iguazio (reported previously) is to provide Israel’s Sheba Medical Center with clinical, real-time predictive insights from its AI Data Science Platform to help optimize care for Covid-19 patients. Iguazio’s systems will also help Sheba reduce delays in transporting patients.

Israel’s Yehonatan Medical together with Sheba Medical Center have devised a ventilation system with a high-power output and built-in disinfecting mechanism that can treat between three and five patients simultaneously. It includes AI technology for alerting and adjusting to patient responsiveness.

Israel’s Exero Medical (reported previously) has received Breakthrough device designation by the US FDA for its implantable biodegradable wireless sensor designed to continuously monitor for gastrointestinal leaks and healing status after surgery.

Jerusalem’s Hadassah-University Medical Center and Israel’s NeuroGenesis have developed a stem cell treatment for patients with progressive multiple sclerosis. A Phase II human trial not only halted progression of the disease but led to improvement in neurological ability.

An end to the coronavirus pandemic is in sight as hundreds of thousands of doses of Pfizer vaccines were flown into Tel Aviv. Vaccinations are due to begin on Dec 27. Israel is scheduled to receive 4 million doses of the vaccine by end Dec.

Progress has been made with the Israeli-developed vaccines and treatments. The MigVax oral vaccine is ideal for developing countries as it easy to transport and distribute. It is also much safer, e.g., for those who have allergies or compromised immune systems.

Israeli-Arab orthopaedists, neurologists, heart surgeons, and mental health experts are in the Gaza Strip relieving the strain on hospitals fighting coronavirus. They are conducting urgent (previously postponed) surgeries on non-Covid-19 patients and training up Palestinian Arab medical teams.